Members of the Trust Board

The non-executive and executive directors of the Trust, who together comprise the Trust Board, are listed below.

Non-executive directors

Peter Hollins 

Peter Hollins, chair

Peter graduated in chemistry from Oxford. In 1973 he joined Imperial Chemical Industries (ICI) where he undertook a series of increasingly senior roles in marketing and then general management. Following three years in the Netherlands as general manager of ICI Resins BV, he was appointed chief operating officer of EVC in Brussels, a joint venture between ICI and Enichem of Italy, in 1992. He played a key role in the flotation of the company in 1994, before returning to the UK in 1998 as chief executive officer of British Energy where he remained until 2001. From 2001 onwards he held various chairmanships and non-executive directorships. In 2003 he decided to return to an executive role as chief executive of the British Heart Foundation, where he remained in post until retirement in March 2013.

 Mr Simon Porter 

Simon Porter, senior independent director and deputy chair

Simon was born and educated in Southampton and then Oxford, graduating with a degree in modern languages (Italian and French). He is a qualified chartered accountant, having spent most of his career with the London office of Ernst & Young, where he specialised first in audit, then in transactions and finally risk management. He was a partner with Ernst & Young from 1994 to 2010. He joined the Trust Board on 1 January 2011 as a designate non-executive director and became non-executive director and co-chair of the audit and assurance committee from 1 June 2011. He has chaired the quality and performance committee since it was established in January 2014. He also holds non-executive board positions in the social housing sector.

Dr Mike Sadler

Dr Mike Sadler

Mike joined us as a clinical non-executive director from the same position at Southern Health NHS Foundation Trust. He works for the CQC as a specialist adviser in primary care and works as an advisor and consultant on health and social care services. He has previously been a non-executive director at a NHS Foundation Trust providing mental health, learning disability and community services. 

Mike was a GP principal in Hampshire before moving into public health medicine. Having achieved MSc with distinction at the London School of Hygiene and Tropical Medicine, he joined Portsmouth and South East Hampshire Health Authority, holding the joint posts of deputy director of public health, and medical adviser. He has since held a series of senior clinical leadership roles in national organisations in both the public and private sector, including as chief operating officer at NHS Direct and Serco’s health division. His last full time role, up until July 2013 when he commenced his portfolio career, was as director of health and social care at West Sussex County Council.

 Jenni Douglas-Todd

Jenni Douglas-Todd

Jenni is a former chief executive of Hampshire Police Authority and the office of the Hampshire Police and Crime Commissioner. After beginning her career in the probation service, she was head hunted into the civil service, at the Home Office, where she spent four years before being becoming director of policy and research for the Independent Police Complaints Commission. In the latter role she was responsible for establishing governance of the new police complaints system. She then spent two and a half years as a resident twinning adviser for the UK, based in Turkey to help set-up a law enforcement complaints system before taking up the role of chief executive of the county’s police authority. During her three years in the post, she supported the authority in developing effective governance processes to increase accountability and transparency while also helping the organisation deliver cost-savings whilst still improving performance and develop closer working relations with neighbouring forces. In 2012, she became chief executive and monitoring officer for the Hampshire Police and Crime Commissioner, where she led the development of the office’s vision, mission, values and organisational strategy. She took on the role of investigating committee chair for the General Dental Council in 2014 and, in April that year, founded the Diversa Consultancy, which supports organisations with changes in business, culture and behaviour. She is also a member of the Judicial Conduct Investigating Office, a public appointment.

 Cyrus Cooper Trust Board photo

Professor Cyrus Cooper

Cyrus Cooper is professor of rheumatology and director of the MRC Lifecourse Epidemiology Unit. He's also vice-dean of the faculty of medicine at the University of Southampton and professor of epidemiology at the Nuffield Department of Orthopaedics (rheumatology and musculoskeletal sciences, University of Oxford).  

He leads an internationally competitive programme of research into the epidemiology of musculoskeletal disorders, most notably osteoporosis. His key research contributions have been:

  • discovery of the developmental influences which contribute to the risk of osteoporosis and hip fracture in late adulthood
  • demonstration that maternal vitamin D insufficiency is associated with sub-optimal bone mineral accrual in childhood
  • characterisation of the definition and incidence rates of vertebral fractures
  • leadership of large pragmatic randomised controlled trials of calcium and vitamin D supplementation in the elderly as immediate preventative strategies against hip fracture.  

He is president of the International Osteoporosis Foundation, chair of the BHF Project Grants Committee, an emeritus NIHR senior investigator, and associate editor of Osteoporosis International. He has previously served as chairman of the Scientific Advisors Committee (International Osteoporosis Foundation), the MRC Population Health Sciences Research Network and the National Osteoporosis Society of Great Britain. He has also been president of the Bone Research Society of Great Britain and has worked on numerous Department of Health, European Community and World Health Organisation committees and working groups.

Prof Cyrus has published extensively (over 900 research papers - hi=119) on osteoporosis and rheumatic disorders and pioneered clinical studies on the developmental origins of peak bone mass. In 2015, he was awarded an OBE for services to medical research.

Jane Bailey (Trust Board)

Jane Bailey

In 1985, Jane joined the pharmaceutical company Glaxo as a management trainee, having graduated from London University with a degree in environmental science and pharmacology.

Here she rose to senior commercial vice president, gaining experience of a broad range of disease areas across different regions of the world. She specialised in leading global research and development teams in the formation of strategies to bring new medicines to patients. She also worked to ensure that the medicines developed were supported by robust evidence demonstrating their clinical and cost effectiveness. In delivering this she gained extensive experience of leading large diverse teams across a complex global organisation.

For five years, Jane ran her own strategy development consultancy, working across a breadth of healthcare organisations. In 2017 Jane gained an MSc in public health, with distinction, at King’s College, London University. Her studies focused on how to ensure the public are engaged in development of healthcare services and how social theories can help inform effective disease prevention and management. She is a director of Healthwatch Portsmouth.

Executive directors

Fiona Dalton   

Fiona Dalton, chief executive

Fiona was appointed as chief executive in 2013. Prior to rejoining the Trust she held the combined position of deputy chief executive and chief operating officer at Great Ormond Street Hospital for Children.

Fiona joined the NHS management training scheme after graduating from Oxford University with a degree in human sciences and began her career in hospital management at Oxford Radcliffe Hospitals NHS Trust in 1996. She then spent four years at UHS as director of strategy and business development before moving to GOSH. 

David French

David French, chief financial officer

David joined the Trust in February 2016 and leads on finance, estates and commercial development. He read economics and social policy at the University of London before joining ICI plc, where he qualified as a chartered management accountant. David has extensive healthcare experience from the pharmaceutical industry, mostly Eli Lilly and Company where he held many commercial and financial roles in the UK and overseas. He joined the NHS in 2010 as chief financial officer of Hampshire Hospitals NHS Foundation Trust. He also serves as a non-executive director for Sentinel Housing Association, a Hampshire-based social housing provider.


Dr Caroline Marshall, chief operating officer

Caroline joined the Trust in 1997 as a consultant hepatobiliary and neuroanaesthetist. She has held the posts of college tutor for the Royal College of Anaesthetists and UHS mentoring and coaching lead. In 2008, she became clinical service director for critical care before holding the position of divisional clinical director between 2010 and 2013. Caroline served as interim chief operating officer before being appointed in December 2014. 

Gail Byrne

Gail Byrne, director of nursing and organisational development

Gail joined the Trust in 2010 as deputy director of nursing and head of patient safety. Prior to this, she has worked at the Strategic Health Authority as head of patient safety, and director of clinical services at Portsmouth Hospital. Gail has also worked in Brisbane, Australia as a hospital Macmillan nurse, and as general manager of a special purpose vehicle company for the private finance initiative at South Manchester Hospitals.

Derek Sandeman 

Dr Derek Sandeman, medical director 

Derek was appointed to the Trust as a consultant physician in 1993 and went on to develop a regional endocrine service. Throughout his career he has had extensive clinical leadership experience, most recently serving eight years as clinical director. Derek’s leadership roles have also included programme director for postgraduate education and the Wessex Endocrine Royal College representative. He has a strong history of wider system engagement, working collaboratively with partners to improve systems resilience and pathways. 


Jane Hayward, director of transformation

Jane joined the Trust in 2000 as clinical services manager for the cardiothoracic directorate after spending two years in Hertfordshire as director of performance and 11 years at Barts and the London Hospitals in various roles including planning, finance and commissioning. Jane has led on human resources, information management and technology, improvement and modernisation and has been chief operating officer. Jane joined the Trust Board in February 2008 and became director of transformation and improvement in January 2014.